Sunday, August 30, 2015 11:04:35 AM
I'm pretty sure my english comprehension is pretty good.
Pray tell .... show us where CEOcast gave reasons "to BUY THE STOCK" ??? There is no statement of recommendation to buy anything. There is no statement indicating an investor should BUY anything.
The first mention is an introduction to the company and what it expects to do the next two years. They do mention in the last sentence of the first newsletter that ZIVO represents an opportunity for a company to capitalize on algae based products. PERIOD. Doesn't say it represents a BUY opportunity.
The second newsletter doesn't give "reasons" for anything ..... simply states what occurred.
Of course the disclaimer mentions no one should do anything without doing their own research and the company editors reserve the right to trade the companies mentioned at any time without disclosure.
Your comment was ZIVO has caused some manipulation of the stock and sent scam email and compared YOUR COMMENT to the activities of a proven recidivist security law violator. If you have some evidence to present ..... by all means ..... present it. Irresponsible and sloppy. Dahl is afraid of his own shadow ....... much less running afoul of securities laws.
You know zero about who what or why the 700,000 share trade occurred unless you yourself pushed the button. Anyone paying attention knows there has been a ton of stock available for sale these last couple weeks even before CEOcast mention. Still are large offers on the board. Stock price hasn't done anything since the mention. In fact, with the exception of the one trade, volume has been waning. Where's the manipulation ?? LOLOLOLOLOL Stock hasn't moved anywhere.
All that can be said ...... ZIVO is obviously paying for the mention. It is money out the window if again Dahl is going to deliver nothing to the market. No point in paying for attention when you deliver zero.
Maybe finalized deal for production scale up gets done soon. Pending funding
Maybe Wellmetris gets something done. Pending funding
Maybe next Zoetis test gets started and timetables are provided that are for once ... adhered too. Pending funding
Hey that's one thing the CEOcast mentions don't say ...... "pending funding". LOLOLOLOL ...
I kinda guess also that signing up for more representation means we won't likely see a buyout soon ..... no point to signing up for public relations if selling out.
Still wondering when the company will move "onward and upward" ........
Amigo Mike
Recent ZIVO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 05:36:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 12:05:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/09/2024 03:49:14 PM
- Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/14/2024 01:16:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:37 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 02/15/2024 01:54:37 PM
- ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study • Business Wire • 02/07/2024 09:54:00 PM
- ZIVO Bioscience Announces Uplisting to OTCQB Market • Business Wire • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:11:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:17:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:12:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 02:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:21:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:18:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/30/2023 05:20:31 PM
- ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens • Business Wire • 10/30/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:56:59 PM
- ZIVO Bioscience Announces Reverse Stock Split • Business Wire • 10/26/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/04/2023 09:08:51 PM
- ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference • GlobeNewswire Inc. • 10/03/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM